Lisanti Capital Growth LLC acquired a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 121,690 shares of the company’s stock, valued at approximately $5,100,000. PROCEPT BioRobotics makes up 1.2% of Lisanti Capital Growth LLC’s […]